Sugammadex
Trade names

Bridion

Sugammadex.svg
Clinical data
Uses

Reversal of neuromuscular blockade from rocuronium and vecuronium

Contraindications

Renal impairment

Routes of administration

Intravenous

Dosage

Based upon response to train-of-four stimulation:

  • 2+ twitches: 2 mg/kg
  • 1-2 posttetanic twitches: 4 mg/kg


Reversal immediately after administration of rocuronium 1.2 mg/kg: 16 mg/kg

Pharmacodynamics
Mechanism of action

Encapsulation of rocuronium or vecuronium

Adverse effects

Bradycardia, may interfere with hormonal contraceptives

Pharmacokinetics
Physical and chemical data
Formula

C72H112O48S8

Molar mass

2002.12 g/mol

Article quality
Editor rating
In development
User likes
0

Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium.

Uses

If a patient requires reparaylsis after administration of sugammadex (up to 4 mg/kg), rocuronium or vecuronium can be re-administered after a minimum waiting time.[1]

Drug and dose to be administered Minimum waiting time
Rocuronium 1.2 mg/kg 5 minutes
Rocuronium 0.6 mg/kg or

vecuronium 0.1 mg/kg

4 hours

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References

  1. "BRIDION® (sugammadex) Injection Drug Label (FDA)" (PDF).